Literature DB >> 10556714

CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole.

N Puri1, S Krishnamurthy, S Habib, S E Hasnain, S K Goswami, R Prasad.   

Abstract

We previously demonstrated that the CDR1 gene, encoding a multidrug transporter in Candida albicans, is differentially upregulated by various drugs and steroids. In order to get an insight into the molecular basis of the induction of this gene we analyzed its promoter region. The transcription start site was mapped to 63 nucleotides upstream of the initiating ATG. Reporter assays revealed the presence of four upstream activating and four upstream repressing sequence domains along the entire promoter. Like the native gene, promoter-luciferase recombinants showed enhanced activity in response to various stresses like drugs, human steroid hormones and heavy metals. Mutational analysis demonstrated that while the proximal promoter (-345/+1) contains all the regulatory domains required for its induction by various other stresses, the miconazole response is mediated via the distal promoter (-857/-1147), harboring an AP-1 site. The involvement of the AP-1 element in mediating the latter effect was evident by an increase in AP-1 binding activity following miconazole treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556714     DOI: 10.1111/j.1574-6968.1999.tb08798.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Identification of azole-responsive genes by microarray technology: why are we missing the efflux transporter genes?

Authors:  D P Kontoyiannis; G S May
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p.

Authors:  Brian G Oliver; Jia L Song; Jake H Choiniere; Theodore C White
Journal:  Eukaryot Cell       Date:  2007-10-19

Review 3.  Multidrug resistance in fungi.

Authors:  Kailash Gulshan; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2007-09-14

4.  Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.

Authors:  Alix T Coste; Jérôme Crittin; Christopher Bauser; Bettina Rohde; Dominique Sanglard
Journal:  Eukaryot Cell       Date:  2009-06-26

5.  Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.

Authors:  Shipra Shukla; Vipin Yadav; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2011-08-19

Review 6.  The ABCs of Candida albicans Multidrug Transporter Cdr1.

Authors:  Rajendra Prasad; Atanu Banerjee; Nitesh Kumar Khandelwal; Sanjiveeni Dhamgaye
Journal:  Eukaryot Cell       Date:  2015-09-25

7.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

8.  CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1.

Authors:  Chia-Geun Chen; Yun-Liang Yang; Hsin-I Shih; Chia-Li Su; Hsiu-Jung Lo
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

9.  Cellular and molecular biology of Candida albicans estrogen response.

Authors:  Georgina Cheng; Kathleen M Yeater; Lois L Hoyer
Journal:  Eukaryot Cell       Date:  2006-01

10.  A genome-wide steroid response study of the major human fungal pathogen Candida albicans.

Authors:  Dibyendu Banerjee; Nuria Martin; Soumyadeep Nandi; Sudhanshu Shukla; Angel Dominguez; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Mycopathologia       Date:  2007-06-16       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.